drugset / Trial / NCT06660069

A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation

NCT06660069

Completed 199 enrolled HALEON
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to assess the ability of a marketed Cetylpyridinium Chloride (CPC) mouthwash alongside a marketed Stannous Fluoride (SnF2) toothpaste in improving gingival health and reducing plaque accumulation, compared to the use of a regular fluoride toothpaste alone in participants with clinically measurable plaque-induced gingivitis.

Timeline

Start
2024-11-18
Primary completion
2025-03-11
Completion
2025-03-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetylpyridinium Small molecule 0.07 % Oral
Comparator sodium fluoride Unknown 0.243 % Oral
Comparator stannous fluoride Small molecule 0.454 % Oral